RA
HHS icon

Royce & Associates’s Harte-Hanks HHS Stock Holding History

Royce & Associates’s Portfolio HHS Stock Details HHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-28,420
Closed -$270K – 1265
2017
Q4 		$270K Sell
28,420
-36,920
-57% -$372K ﹤0.01% 1077
2017
Q3 		$699K Sell
65,340
-4,007
-6% -$36.9K ﹤0.01% 1004
2017
Q2 		$714K Sell
69,347
-2,210
-3% -$27.9K ﹤0.01% 1017
2017
Q1 		$1M Hold
71,557
– – 0.01% 981
2016
Q4 		$1.08M Sell
71,557
-15,533
-18% -$235K 0.01% 926
2016
Q3 		$1.41M Buy
87,090
+6,750
+8% +$111K 0.01% 872
2016
Q2 		$1.28M Buy
80,340
+17,683
+28% +$312K 0.01% 882
2016
Q1 		$1.58M Sell
62,657
-18,239
-23% -$560K 0.01% 866
2015
Q4 		$2.62M Buy
80,896
+34,310
+74% +$1.28M 0.02% 803
2015
Q3 		$1.64M Sell
46,586
-111,617
-71% -$5.04M 0.01% 903
2015
Q2 		$9.43M Buy
158,203
+4,706
+3% +$316K 0.04% 557
2015
Q1 		$12M Buy
153,497
+44,759
+41% +$3.46M 0.05% 517
2014
Q4 		$8.42M Buy
108,738
+13,002
+14% +$850K 0.03% 653
2014
Q3 		$6.1M Hold
95,736
– – 0.02% 764
2014
Q2 		$6.88M Buy
95,736
+23,097
+32% +$1.78M 0.02% 786
2014
Q1 		$6.42M Buy
72,639
+71,480
+6,167% +$5.56M 0.02% 814
2013
Q4 		$91K Buy
1,159
+230
+25% +$18.7K ﹤0.01% 1362
2013
Q3 		$82K Sell
929
-1,350
-59% -$124K ﹤0.01% 1370
2013
Q2 		$196K Buy
+2,279
New +$189K ﹤0.01% 1292

Other funds holding HHS

FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
EVC
Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Foundry Partners Minneapolis, Minnesota $1.89B AUM 9.84% 1-Year Est. Return

Royce & Associates's HHS Position: Q1 2018 in Review

Royce & Associates sold out of Harte-Hanks (HHS) in Q1 2018, closing a stake of 28,420 shares — an estimated $270K sold.

Royce & Associates first reported a position in HHS in Q2 2013 and held it in 19 quarters. The position peaked at $12M in Q1 2015. 28 funds tracked by Wall St. Rank hold HHS as of Q1 2018.

  • Royce & Associates reported no remaining Harte-Hanks position as of Q1 2018 after selling out during the quarter.
  • Royce & Associates sold 28,420 Harte-Hanks shares in Q1 2018, an estimated $270K.
  • Royce & Associates first reported a position in Harte-Hanks in Q2 2013 and held it in 19 quarters.
  • Royce & Associates's Harte-Hanks position peaked at $12M in Q1 2015.
  • 28 funds tracked by Wall St. Rank held Harte-Hanks as of Q1 2018.

Based on Royce & Associates's 13F filing for Q1 2018, filed 14 May 2018.